Stockscreener 앱 받기
46.85
1.65%
0.76
시간 외 거래:
46.85
전일 마감가:
$46.09
열려 있는:
$46.58
하루 거래량:
355.26K
Relative Volume:
0.87
시가총액:
$985.99M
수익:
$1.77M
순이익/손실:
$-123.74M
주가수익비율:
-5.1091
EPS:
-9.17
순현금흐름:
$-95.21M
1주 성능:
+2.88%
1개월 성능:
-1.97%
6개월 성능:
+23.78%
1년 성능:
-20.65%
1일 변동 폭
$45.81
$47.83
1주일 범위
$44.13
$47.83
52주 변동 폭
$26.70
$91.83
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
명칭
Praxis Precision Medicines Inc
전화
617-300-8460
주소
99 HIGH STREET, 30TH FLOOR, BOSTON
PRAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
46.85 | 970.00M | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-07 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-03 | 재확인 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-08-05 | 개시 | Oppenheimer | Outperform |
| 2024-06-24 | 개시 | Needham | Buy |
| 2024-06-18 | 개시 | Guggenheim | Buy |
| 2024-05-01 | 개시 | Robert W. Baird | Outperform |
| 2023-09-19 | 개시 | Truist | Buy |
| 2022-06-06 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-12-16 | 개시 | H.C. Wainwright | Buy |
| 2021-08-26 | 개시 | BofA Securities | Buy |
| 2021-04-26 | 개시 | William Blair | Outperform |
| 2020-11-11 | 개시 | Wedbush | Outperform |
| 2020-11-10 | 개시 | Cowen | Outperform |
| 2020-11-10 | 개시 | Evercore ISI | Outperform |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스
Risk adjusted return profile for Praxis Precision Medicines Inc. analyzedAnalyst Downgrade & Accurate Buy Signal Alerts - Newser
How does Praxis Precision Medicines Inc. score in quality rankingsJuly 2025 Gainers & Verified Chart Pattern Signals - خودرو بانک
Will Praxis Precision Medicines Inc. outperform during market ralliesForecast Cut & Low Risk High Reward Ideas - خودرو بانک
Why is Praxis Precision Medicines Inc. stock going downJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - خودرو بانک
Invesco Ltd. Sells 75,305 Shares of Praxis Precision Medicines, Inc. $PRAX - Defense World
Analysts Set Expectations for PRAX Q3 Earnings - Defense World
Praxis Precision Medicines ends ATM agreement with Jefferies, initiates new $250 million program with TD Cowen - Investing.com South Africa
Strategic Shift in Capital Raising: Praxis Precision Medicines' Transition from Jefferies to TD Securities - AInvest
Praxis Precision Medicines terminates 2024 sales agreement with JefferiesSEC filing - MarketScreener
Praxis Precision Medicines Signs New Sales Agreement - TipRanks
SEC Form 424B5 filed by Praxis Precision Medicines Inc. - Quantisnow
Can swing trading help recover from Praxis Precision Medicines Inc. losses2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
Will Praxis Precision Medicines Inc. benefit from macro trendsTrade Risk Assessment & Daily Entry Point Trade Alerts - Newser
Will Praxis Precision Medicines Inc. benefit from current market trends2025 Macro Impact & Smart Swing Trading Alerts - خودرو بانک
Has Praxis Precision Medicines Inc. formed a bullish divergenceWeekly Investment Report & Safe Entry Point Identification - Newser
Should you wait for a breakout in Praxis Precision Medicines Inc.CEO Change & AI Enhanced Market Trend Forecasts - Newser
Smart tools for monitoring Praxis Precision Medicines Inc.’s price actionMarket Rally & Verified Momentum Stock Watchlist - Newser
Comparing Praxis Precision Medicines Inc. in custom built stock radarsGap Down & Community Driven Trade Alerts - Newser
What earnings revisions data tells us about Praxis Precision Medicines Inc.Oil Prices & Target Return Focused Stock Picks - Newser
Reversal indicators forming on Praxis Precision Medicines Inc. stockPortfolio Gains Report & High Win Rate Trade Alerts - Newser
What MACD signals say about Praxis Precision Medicines Inc.Earnings Risk Report & Community Verified Trade Alerts - Newser
Praxis Precision Medicines to Participate in September Investor Conferences - GlobeNewswire
Praxis Precision Medicines to Participate in September Investor Conferences | PRAX Stock News - GuruFocus
Praxis Precision Medicines to Present at Upcoming Investor Conferences in September 2025 - Quiver Quantitative
CNS Drug Developer Praxis Precision Medicines Set for Baird, Wainwright, and TD Cowen Conferences - Stock Titan
What candlestick patterns are forming on Praxis Precision Medicines Inc.Portfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Bragar Eagel & Squire, P.C. Is Investigating Praxis, Align, - GlobeNewswire
How sentiment analysis helps forecast Praxis Precision Medicines Inc.Portfolio Risk Summary & Community Driven Trade Alerts - Newser
Short interest data insights for Praxis Precision Medicines Inc.Profit Target & AI Based Trade Execution Alerts - Newser
Order flow analysis tools used on Praxis Precision Medicines Inc.Trade Risk Summary & Short-Term High Return Ideas - Newser
Sector ETF performance correlation with Praxis Precision Medicines Inc.Market Movement Recap & Detailed Earnings Play Alerts - Newser
Will Praxis Precision Medicines Inc. benefit from rate cutsTrade Entry Report & Smart Allocation Stock Reports - خودرو بانک
How does Praxis Precision Medicines Inc. perform in inflationary periods2025 Price Action Summary & Weekly Sector Rotation Insights - خودرو بانک
Praxis Precision Medicines’ Strategic Talent Acquisition and Equity Incentive Structure - AInvest
Does Praxis Precision Medicines Inc. fit your quant trading modelWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - Newser
Does Praxis Precision Medicines Inc. outperform in volatile marketsPortfolio Update Report & Reliable Entry Point Alerts - خودرو بانک
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
CNS Drug Developer Praxis Precision Medicines Issues 6,238 RSUs Under 2024 Inducement Plan - Stock Titan
Can Praxis Precision Medicines Inc. keep up with sector leaders2025 Volatility Report & Accurate Entry and Exit Point Alerts - خودرو بانک
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc.PRAX - PR Newswire
How to manage a losing position in Praxis Precision Medicines Inc.Volume Spike & Verified Chart Pattern Signals - Newser
Praxis Precision Medicines Inc. stock chart pattern explainedWeekly Trade Recap & AI Based Buy/Sell Signal Reports - Newser
Is Praxis Precision Medicines Inc. a speculative investmentJuly 2025 Summary & Stepwise Trade Signal Guides - خودرو بانک
Momentum divergence signals in Praxis Precision Medicines Inc. chartJuly 2025 Big Picture & Step-by-Step Swing Trade Plans - Newser
Short interest data insights for Praxis Precision Medicines IncJuly 2025 Institutional & High Conviction Buy Zone Picks - Newser
Signal strength of Praxis Precision Medicines Inc. stock in tech scanners - Newser
Is Praxis Precision Medicines Inc. a potential multi baggerRate Cut & AI Driven Price Predictions - خودرو بانک
Praxis Precision Medicines Inc (PRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Praxis Precision Medicines Inc 주식 (PRAX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nemiroff Alex | General Counsel and Secretary |
Nov 14 '24 |
Sale |
80.20 |
8,239 |
660,827 |
10,301 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Option Exercise |
56.94 |
4,374 |
249,056 |
10,801 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Sale |
81.78 |
5,188 |
424,318 |
5,613 |
1.40%
자본화:
|
볼륨(24시간):